Methods for quantification of amyloid β peptides in plasma by mass spectrometry
AssigneeAraclon Biotech, S.L.
InventorsJose Antonio Allue Blasco, Maria Leticia Sarasa Coronas
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for preparing a plasma sample comprising amyloid beta peptides for analysis by mass spectrometry, comprising the steps of: a) contacting said plasma sample with a denaturing agent, b) performing a first solid phase extraction step on the solution obtained in step a) to recover a first eluate, c) performing a second solid phase extraction step on said first eluate obtained in step b) to recover a second eluate, and d) drying said second eluate obtained in step c) and processing it for analysis by mass spectrometry, wherein the solution obtained in step d) comprises intact amyloid beta peptides Aβ40 and Aβ42.
Claims15
A method for preparing a plasma sample comprising amyloid beta peptides for analysis by mass spectrometry, wherein the plasma sample comprises intact amyloid beta peptides Aβ40 and Aβ42, comprising:
- a) contacting said plasma sample with a denaturing agent to obtain a denatured solution;
- b) performing a first solid phase extraction on the denatured solution to recover a first eluate,
- c) performing a second solid phase extraction step on said first eluate to recover a second eluate, and
- d) drying said second eluate and processing the dried second eluate for analysis by mass spectrometry to obtain the plasma sample,
- wherein the first solid phase extraction step is a reversed-phase solid phase extraction and the second solid phase extraction step is a cation exchange solid phase extraction,
- wherein the first solid phase extraction step is an anion exchange solid phase extraction and the second solid phase extraction step is a cation exchange solid phase extraction, or
- wherein the first solid phase extraction step is a cation exchange solid phase extraction and the second solid phase extraction step is an anion exchange solid phase extraction,
- and
- wherein the denaturing agent is an acidic denaturing agent if the first solid phase extraction step is a reversed-phase solid phase extraction or a cation exchange solid phase extraction, or
- wherein the denaturing agent is a basic denaturing agent if the first solid phase extraction step is an anion exchange solid phase extraction.
Dependencies are inferred from the claim text.